M. Torres-Tortosa

1.2k total citations
25 papers, 872 citations indexed

About

M. Torres-Tortosa is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, M. Torres-Tortosa has authored 25 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 14 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in M. Torres-Tortosa's work include Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and HIV/AIDS drug development and treatment (5 papers). M. Torres-Tortosa is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and HIV/AIDS drug development and treatment (5 papers). M. Torres-Tortosa collaborates with scholars based in Spain, Chile and Australia. M. Torres-Tortosa's co-authors include Jesús Rodríguez‐Baño, Alfonso del Arco, Juan E. Corzo, Antonio Sánchez-Porto, Andrés Martín-Aspas, Mercedes González‐Serrano, María Dolores López-Prieto, A Arroyo, Pilar Retamar and Ángel Muñiz Muñoz and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

M. Torres-Tortosa

24 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Torres-Tortosa Spain 16 498 332 276 181 160 25 872
Francisco Gudiol Spain 13 683 1.4× 240 0.7× 95 0.3× 179 1.0× 125 0.8× 23 1.2k
Antonio Sánchez-Porto Spain 13 379 0.8× 140 0.4× 166 0.6× 123 0.7× 130 0.8× 48 1.0k
Jun Seong Son South Korea 18 476 1.0× 385 1.2× 199 0.7× 128 0.7× 75 0.5× 46 1.0k
Ernesto G. Scerpella United States 16 476 1.0× 527 1.6× 125 0.5× 93 0.5× 65 0.4× 28 1.1k
Eric McGrath United States 16 362 0.7× 177 0.5× 86 0.3× 64 0.4× 154 1.0× 58 904
Christian Chuard Switzerland 17 486 1.0× 415 1.3× 271 1.0× 32 0.2× 154 1.0× 49 1.1k
Keri K. Hall United States 8 630 1.3× 263 0.8× 488 1.8× 84 0.5× 389 2.4× 9 1.1k
Narin Bak Australia 13 478 1.0× 669 2.0× 308 1.1× 85 0.5× 110 0.7× 19 1.0k
Mark Melzer United Kingdom 11 354 0.7× 251 0.8× 181 0.7× 130 0.7× 134 0.8× 44 833
J W Dorigo-Zetsma Netherlands 17 589 1.2× 210 0.6× 70 0.3× 89 0.5× 132 0.8× 36 962

Countries citing papers authored by M. Torres-Tortosa

Since Specialization
Citations

This map shows the geographic impact of M. Torres-Tortosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Torres-Tortosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Torres-Tortosa more than expected).

Fields of papers citing papers by M. Torres-Tortosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Torres-Tortosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Torres-Tortosa. The network helps show where M. Torres-Tortosa may publish in the future.

Co-authorship network of co-authors of M. Torres-Tortosa

This figure shows the co-authorship network connecting the top 25 collaborators of M. Torres-Tortosa. A scholar is included among the top collaborators of M. Torres-Tortosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Torres-Tortosa. M. Torres-Tortosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toro, María Dolores del, I. Nieto, Juan E. Corzo, et al.. (2014). Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures. European Journal of Clinical Microbiology & Infectious Diseases. 33(8). 1439–1448. 25 indexed citations
2.
Rodríguez‐Baño, Jesús, María Dolores López-Prieto, Pilar Retamar, et al.. (2009). Epidemiology and Clinical Features of Community-Acquired, Healthcare Associated and Nosocomial Bloodstream Infections in Tertiary and Community Hospitals. Clinical Microbiology and Infection. 16(9). 1408–13. 90 indexed citations
3.
Mira, José Antonio López, Alicia Gutiérrez‐Valencia, Ignacio de los Santos, et al.. (2009). Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression. Clinical Infectious Diseases. 49(8). e84–e91. 14 indexed citations
4.
Rivero, Antonio, Inés Pérez‐Camacho, Fernando Lozano, et al.. (2008). Etiology of spontaneous pneumothorax in 105 HIV-infected patients without highly active antiretroviral therapy. European Journal of Radiology. 71(2). 264–268. 15 indexed citations
5.
Mira, J, Luís F. López‐Cortés, Pablo Barreiro, et al.. (2008). Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone. Journal of Antimicrobial Chemotherapy. 62(6). 1365–1373. 47 indexed citations
6.
Mira, José Antonio López, Luís F. López‐Cortés, Dolores Merino, et al.. (2007). Predictors of Severe Haematological Toxicity Secondary to Pegylated Interferon plus Ribavirin Treatment in HIV-HCV-Coinfected Patients. Antiviral Therapy. 12(8). 1225–1236. 40 indexed citations
7.
Santos, Jesús, Rosario Palacios, Miguel José López, et al.. (2005). Simplicity and Efficacy of a Once-Daily Antiretroviral Regimen with Didanosine, Lamivudine, and Efavirenz in Naïve Patients: The VESD Study. HIV Clinical Trials. 6(6). 320–328. 15 indexed citations
8.
Torres-Tortosa, M., et al.. (2003). Prognosis and Clinical Evaluation of Infection Caused by Rhodococcus equi in HIV-Infected Patientsa. CHEST Journal. 123(6). 1970–1976. 64 indexed citations
9.
Cordero, Elisa, et al.. (2002). Usefulness of Sputum Culture for Diagnosis of Bacterial Pneumonia in HIV-Infected Patients. European Journal of Clinical Microbiology & Infectious Diseases. 21(5). 362–367. 30 indexed citations
10.
Torres-Tortosa, M., et al.. (2002). Prognostic Evaluation of Bacteremia and Fungemia in Patients with Acquired Immunodeficiency Syndrome. European Journal of Clinical Microbiology & Infectious Diseases. 21(4). 262–268. 6 indexed citations
11.
Cordero, Elisa, Jerónimo Pachón, Antonio Rivero, et al.. (2000). Community-Acquired Bacterial Pneumonia in Human Immunodeficiency Virus–Infected Patients. American Journal of Respiratory and Critical Care Medicine. 162(6). 2063–2068. 47 indexed citations
12.
Cordero, Elisa, Jerónimo Pachón, Antonio Rivero, et al.. (2000). Haemophilus influenzae Pneumonia in Human Immunodeficiency Virus-Infected Patients. Clinical Infectious Diseases. 30(3). 461–465. 30 indexed citations
13.
Torres-Tortosa, M., et al.. (2000). Disminución de la frecuencia anual de endocarditis infecciosa en usuarios de drogas intravenosas en el sur de España. 18(6). 293–294. 3 indexed citations
14.
Torres-Tortosa, M., et al.. (1998). Sobre un «Proyecto de programa nacional de control de la tuberculosis para España». 111(15). 597–599. 1 indexed citations
15.
Sánchez-Porto, Antonio, et al.. (1997). [Bacteremias due to the Streptococcus milleri group. An analysis of 18 episodes].. PubMed. 197(6). 393–7. 3 indexed citations
16.
Lozano, Fernando, José Miguel Cisneros, J. Polo, et al.. (1996). Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. European Journal of Clinical Microbiology & Infectious Diseases. 15(9). 705–711. 22 indexed citations
17.
Torres-Tortosa, M., et al.. (1995). [Changes in heroin administration route and frequency of human immunodeficiency virus infection].. PubMed. 104(7). 249–52. 2 indexed citations
18.
Torres-Tortosa, M., et al.. (1994). Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. European Journal of Clinical Microbiology & Infectious Diseases. 13(7). 559–564. 56 indexed citations
19.
Sánchez-Porto, Antonio, et al.. (1994). [Bacteremia caused by Campylobacter jeikeium in 2 AIDS patients without neutropenia].. PubMed. 12(1). 31–3. 4 indexed citations
20.
Torres-Tortosa, M., et al.. (1992). [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].. PubMed. 99(20). 766–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Gudiol Breakdown of academic impact, for papers by Antonio Sánchez-Porto Breakdown of academic impact, for papers by Jun Seong Son Breakdown of academic impact, for papers by Ernesto G. Scerpella Breakdown of academic impact, for papers by Eric McGrath Breakdown of academic impact, for papers by Christian Chuard Breakdown of academic impact, for papers by Keri K. Hall Breakdown of academic impact, for papers by Narin Bak Breakdown of academic impact, for papers by Mark Melzer Breakdown of academic impact, for papers by J W Dorigo-Zetsma
Rankless by CCL
2026